FDA Approves Penpulimab-Kcqz for Indications in Nonkeratinizing Nasopharyngeal Carcinoma

Source: Pharmacy Times articles

The treatment received indications as a monotherapy and in combination regimen with carboplatin or cisplatin and gemcitabine.
Read More